Prolonged agammaglobulinemia despite unaltered B-cell lymphopoiesis after peritransplant-rituximab administration in a child

Transplantation

Volumn 86, Issue 9, 2008, Pages 1322-1323

  Guérin, Valérie ^a   Yakouben, Karima ^a   Lescoeur, Brigitte ^a   Pédron, Béatrice ^a   Dalle, Jean Hugues ^a   Baruchel, André ^a   Sterkers, Ghislaine ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; RITUXIMAB; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; AGAMMAGLOBULINEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; EPSTEIN BARR VIRUS; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; JUVENILE MYELOMONOCYTIC LEUKEMIA; LETTER; LYMPHOPOIESIS; LYMPHOPROLIFERATIVE DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION; DRUG EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MALE; METABOLISM;

AGAMMAGLOBULINEMIA; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTORS; INFANT; LEUKEMIA, MYELOMONOCYTIC, JUVENILE; LYMPHOPOIESIS; MALE; TRANSPLANTATION CONDITIONING;

EID: 58149173401     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318188ac0c     Document Type: Letter

References (8)

1. + T Cell responses to cytomegalovirus between human fetuses and their transmitter mothers. J Infect Dis 2007; 196: 1033.
2. Greally JF, Lawlor E, Lyons J, et al. Acquired hypogammaglobulinemia following infectious mononucleosis. J Clin Immunol 1983; 3: 207.
3. Purtilo DT. X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma. Arch Pathol Lab Med 1981; 105:119.
4. Seemayer TA, Gross TG, Egeler RM, et al. X-linked lymphoproliferative disease: Twenty-five years after the discovery. Pediatr Res 1995; 38: 471.
5. Zuccaro G, Della Bella S, Polizzi B, et al. Common variable immunodeficiency following Epstein-Barr virus infection. J Clin Lab Immunol 1997; 49: 41.
6. + T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection. Blood 2004; 103:1625.
7. Nishio M, Fujimoto K, Yamamoto S, et al. Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma. Eur J Haematol 2006; 77: 226.
8. Nishio M, Fujimoto K, Yamamoto S, et al. Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation. Br J Haematol 2007; 137:349.1.